 DALLAS, March 12, 2021 PRNewswire -- Lantern Pharma Inc. NASDAQ: LTRN, a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence A.I. platform to transform oncology drug discovery and development, today announced that an interview with CEO Panna Sharma will air on The RedChip Money Report on Bloomberg TV in the US on Saturday, March 13, at 7 p.m. 